~9 spots leftby Sep 2025

High vs Low Glycemic Index Meals for Cystic Fibrosis

Recruiting in Palo Alto (17 mi)
TD
Overseen byTanicia Daley, MD, MPH
Age: < 65
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Emory University
Must not be taking: Glucocorticoids
Disqualifiers: Pulmonary exacerbation, Liver transplant, CFRD, others
No Placebo Group

Trial Summary

What is the purpose of this trial?

The goal of this study is to determine the extent to which excess dietary simple sugars serve as a secondary mediating factor in Cystic fibrosis-related diabetes (CFRD) development. The main questions it aims to answer are: * Whether conducting a randomized 2x2 factorial design that evaluates acute postprandial changes in glucose over 2 hours following ingestion of a mixed meal challenge that varies by glycemic index and consumption of a sugar-sweetened beverage is acceptable and feasible. * What are the preliminary changes in postprandial hyperglycemia, islet cell function, and incretin response to a high or low Glycemic Index mixed meal tolerance test (MMTT) with and without Sugar-Sweetened Beverages (SSB) in adolescents and young adults with CF Participants will be randomized to a mixed diet and blood will be drawn before and after the mixed meal challenge.

Will I have to stop taking my current medications?

If you are currently using medications that affect blood sugar levels, you will need to stop them at least 4 weeks before joining the study. However, if you are using CFTR modulators, you can continue them as long as you've been on them for at least 2 months.

What data supports the effectiveness of the treatment High vs Low Glycemic Index Meals for Cystic Fibrosis?

There is insufficient evidence to recommend the use of low glycemic index diets specifically for cystic fibrosis, but low glycemic index diets have shown benefits in managing blood sugar levels in other types of diabetes, suggesting potential benefits for cystic fibrosis-related diabetes.12345

Is it safe for humans to consume high or low glycemic index meals?

Research on high and low glycemic index meals, often studied in people with diabetes or insulin resistance, generally shows no significant safety concerns. These studies focus on blood sugar responses and do not report harmful effects, suggesting that these meals are safe for human consumption.678910

How is the High vs Low Glycemic Index Mixed Meal Tolerance Test treatment different from other treatments for cystic fibrosis?

This treatment is unique because it focuses on the glycemic index (GI) of meals, which measures how quickly foods raise blood sugar levels, to manage glucose and lipid metabolism in cystic fibrosis patients. Unlike standard treatments that may not consider meal composition, this approach uses high and low GI meals to potentially improve glycemic control and overall metabolic health in CF patients.13111213

Research Team

TD

Tanicia Daley, MD, MPH

Principal Investigator

Emory University

Eligibility Criteria

This study is for adolescents and young adults with Cystic Fibrosis. It's designed to see if different types of sugar in meals affect their blood sugar levels and insulin function. Participants will be given meals with high or low glycemic index sugars, some including sugary drinks.

Inclusion Criteria

English speaking
My pancreas does not work properly.
I consume a lot of added sugars and drink sugary beverages weekly.
See 1 more

Exclusion Criteria

Restrictive dietary patterns (e.g, vegan, ketogenic, intermittent fasting) for more than one month within the last two months prior to screening
My BMI is either very low or very high for my age and sex.
I have been diagnosed with cystic fibrosis-related liver disease.
See 14 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo a randomized 2x2 factorial design evaluating acute postprandial changes in glucose over 2 hours following ingestion of a mixed meal challenge

2 hours per session
Multiple sessions (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Long-term Monitoring

Monitoring of primary and secondary outcome measures such as acceptability, retention rates, and changes in plasma markers

2 years

Treatment Details

Interventions

  • High vs Low Glycemic Index Mixed Meal Tolerance Test (Behavioural Intervention)
Trial OverviewThe trial tests how the body reacts to meals that have sugars which are absorbed at different rates (high vs low glycemic index) and whether adding a sugary drink makes a difference. Blood samples before and after eating measure changes in glucose, insulin function, and hormones related to digestion.
Participant Groups
4Treatment groups
Experimental Treatment
Group I: SSB+ HI- GIExperimental Treatment2 Interventions
All standardized mixed meal challenges will be similar in calories (kcal) and percent of calories from carbohydrates (45%), protein (15%), and fat (40%). Each meal will provide 1/3rd of the subject's estimated kcal needs per current CF nutrition guidelines
Group II: SSB + LO- GIExperimental Treatment2 Interventions
All standardized mixed meal challenges will be similar in calories (kcal) and percent of calories from carbohydrates (45%), protein (15%), and fat (40%). Each meal will provide 1/3rd of the subject's estimated kcal needs per current CF nutrition guidelines
Group III: NSSB+ LO- GIExperimental Treatment1 Intervention
All standardized mixed meal challenges will be similar in calories (kcal) and percent of calories from carbohydrates (45%), protein (15%), and fat (40%). Each meal will provide 1/3rd of the subject's estimated kcal needs per current CF nutrition guidelines
Group IV: NSSB+ HI- GIExperimental Treatment1 Intervention
All standardized mixed meal challenges will be similar in calories (kcal) and percent of calories from carbohydrates (45%), protein (15%), and fat (40%). Each meal will provide 1/3rd of the subject's estimated kcal needs per current CF nutrition guidelines

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
Center for Advanced Pediatrics: Emory HealthcareAtlanta, GA
Loading ...

Who Is Running the Clinical Trial?

Emory University

Lead Sponsor

Trials
1735
Patients Recruited
2,605,000+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials
2513
Patients Recruited
4,366,000+

Findings from Research

Oral glucose tolerance testing in cystic fibrosis: correlations with clinical parameters and glycosylated haemoglobin determinations.De Schepper, J., Dab, I., Derde, MP., et al.[2022]
[Study of the frequency of diabetes mellitus and glucose intolerance in patients with cystic fibrosis]Castro, FA., Fernandes, MI., Júnior, RM., et al.[2020]
Low glycaemic index dietary interventions in youth with cystic fibrosis: a systematic review and discussion of the clinical implications.Balzer, BW., Graham, CL., Craig, ME., et al.[2021]
[Glucose homeostasis in mucoviscidosis].Skopnik, H., Schüttler, A., Döhmen, H., et al.[2022]
Use of hemoglobin A1c to identify dysglycemia in cystic fibrosis.Darukhanavala, A., Van Dessel, F., Ho, J., et al.[2022]
The argument against glycemic index: what are the other options?Franz, MJ.[2019]
High and low glycemic index mixed meals and blood glucose in youth with type 2 diabetes or impaired glucose tolerance.Gellar, L., Nansel, TR.[2021]
Does food insulin index in the context of mixed meals affect postprandial metabolic responses and appetite in obese adolescents with insulin resistance? A randomised cross-over trial.Caferoglu, Z., Hatipoglu, N., Gokmen Ozel, H.[2020]
Effect of high and low glycemic index breakfast on postprandial metabolic parameters and satiety in subjects with type 2 diabetes mellitus under intensive insulin therapy: Controlled clinical trial.Lobos, DR., Vicuña, IA., Novik, V., et al.[2018]
The influence of glycemic index on cognitive functioning: a systematic review of the evidence.Philippou, E., Constantinou, M.[2023]
Dysregulated insulin in pancreatic insufficient cystic fibrosis with post-prandial hypoglycemia.Kilberg, MJ., Sheikh, S., Stefanovski, D., et al.[2021]
Dichotomy between postprandial glucose and lipid profiles in adults with cystic fibrosis: a pilot study.Hammana, I., Coderre, L., Potvin, S., et al.[2011]
Screening for cystic fibrosis-related diabetes and prediabetes: Evaluating 1,5-anhydroglucitol, fructosamine, glycated albumin, and hemoglobin A1c.Tommerdahl, KL., Brinton, JT., Vigers, T., et al.[2022]

References

Oral glucose tolerance testing in cystic fibrosis: correlations with clinical parameters and glycosylated haemoglobin determinations. [2022]
[Study of the frequency of diabetes mellitus and glucose intolerance in patients with cystic fibrosis] [2020]
Low glycaemic index dietary interventions in youth with cystic fibrosis: a systematic review and discussion of the clinical implications. [2021]
[Glucose homeostasis in mucoviscidosis]. [2022]
Use of hemoglobin A1c to identify dysglycemia in cystic fibrosis. [2022]
The argument against glycemic index: what are the other options? [2019]
High and low glycemic index mixed meals and blood glucose in youth with type 2 diabetes or impaired glucose tolerance. [2021]
Does food insulin index in the context of mixed meals affect postprandial metabolic responses and appetite in obese adolescents with insulin resistance? A randomised cross-over trial. [2020]
Effect of high and low glycemic index breakfast on postprandial metabolic parameters and satiety in subjects with type 2 diabetes mellitus under intensive insulin therapy: Controlled clinical trial. [2018]
10.United Statespubmed.ncbi.nlm.nih.gov
The influence of glycemic index on cognitive functioning: a systematic review of the evidence. [2023]
Dysregulated insulin in pancreatic insufficient cystic fibrosis with post-prandial hypoglycemia. [2021]
Dichotomy between postprandial glucose and lipid profiles in adults with cystic fibrosis: a pilot study. [2011]
Screening for cystic fibrosis-related diabetes and prediabetes: Evaluating 1,5-anhydroglucitol, fructosamine, glycated albumin, and hemoglobin A1c. [2022]